Clinical Trial Update: Effect of Different Dosing Regimens of Clopidogrel Before Elective Percutaneous Coronary Intervention (PCI) on Platelet Function [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating different dosing regimens of clopidogrel before elective percutaneous coronary intervention to assess effects on platelet function in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED